BlackRock’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146M | Sell |
6,846,667
-1,550,889
| -18% | -$33M | ﹤0.01% | 1790 |
|
|
2025
Q1 | $162M | Sell |
8,397,556
-33,968
| -0.4% | -$655K | ﹤0.01% | 1705 |
|
|
2024
Q4 | $150M | Buy |
8,431,524
+336,839
| +4% | +$6.01M | ﹤0.01% | 1811 |
|
|
2024
Q3 | $177M | Buy |
8,094,685
+196,100
| +2% | +$4.29M | ﹤0.01% | 1720 |
|
|
2024
Q2 | $61.6M | Sell |
7,898,585
-1,924,756
| -20% | -$15M | ﹤0.01% | 2268 |
|
|
2024
Q1 | $40.7M | Buy |
9,823,341
+63,958
| +0.7% | +$265K | ﹤0.01% | 2515 |
|
|
2023
Q4 | $25.5M | Buy |
9,759,383
+782,464
| +9% | +$2.04M | ﹤0.01% | 2815 |
|
|
2023
Q3 | $16.8M | Buy |
8,976,919
+214,078
| +2% | +$400K | ﹤0.01% | 2992 |
|
|
2023
Q2 | $22M | Buy |
8,762,841
+6,917,788
| +375% | +$17.4M | ﹤0.01% | 2928 |
|
|
2023
Q1 | $3.23M | Buy |
1,845,053
+1,310,393
| +245% | +$2.29M | ﹤0.01% | 3752 |
|
|
2022
Q4 | $2.27M | Buy |
534,660
+113,574
| +27% | +$483K | ﹤0.01% | 4010 |
|
|
2022
Q3 | $500K | Buy |
421,086
+118,878
| +39% | +$141K | ﹤0.01% | 4643 |
|
|
2022
Q2 | $302K | Sell |
302,208
-1,062,985
| -78% | -$1.06M | ﹤0.01% | 4830 |
|
|
2022
Q1 | $3.34M | Sell |
1,365,193
-35,547
| -3% | -$87.1K | ﹤0.01% | 4081 |
|
|
2021
Q4 | $3.77M | Buy |
1,400,740
+200,150
| +17% | +$538K | ﹤0.01% | 4057 |
|
|
2021
Q3 | $6.02M | Buy |
1,200,590
+105,443
| +10% | +$528K | ﹤0.01% | 3825 |
|
|
2021
Q2 | $8.17M | Buy |
1,095,147
+348,045
| +47% | +$2.6M | ﹤0.01% | 3648 |
|
|
2021
Q1 | $4.39M | Buy |
747,102
+16,492
| +2% | +$96.8K | ﹤0.01% | 3938 |
|
|
2020
Q4 | $3.43M | Buy |
+730,610
| New | +$3.43M | ﹤0.01% | 3777 |
|